EUVIMEDEUVIMED entdecken
Crossref

Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2

Fulian Lyu, Huanle Gong, Xiaojin Wu, Xin Liu, Yinghao Lu, Xiya Wei, Chenchen Liu, Yaoyao Shen, Yuhang Wang, Lei Lei, Jia Chen, Shoubao Ma und 5 weitere

Leukemia · 2025

DOI: 10.1038/s41375-024-02475-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Leukemia, 2025. Verfasst von Fulian Lyu und 16 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Ins…. Hauptthemen laut MEDLINE: Graft vs Host Disease, NF-E2-Related Factor 2, Dimethyl Fumarate, Cell Differentiation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseNF-E2-Related Factor 2Dimethyl FumarateCell DifferentiationT-Lymphocytes, Helper-InducerT Follicular Helper CellsAnimalsMiceHumansHematopoietic Stem Cell TransplantationChronic DiseaseMice, Inbred C57BLMaleFemaleInterleukinsDisease Models, AnimalInterleukin-21

Substanzen

NF-E2-Related Factor 2Dimethyl FumarateNfe2l2 protein, mouseNFE2L2 protein, humanInterleukinsInterleukin-21

Autor:innen und Institutionen

  • National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation C…
  • Key Laboratory of Stem Cells and Biomedical Materials of Jiangsu Province and Chinese Ministry of Science and Technology, Suzhou, China.
  • Key Laboratory of Stem Cells and Biomedical Materials of Jiangsu Province and Chinese Ministry of Science and Technology, Suzhou, China. happy_kung@163.com.
  • Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.
  • Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.

Zitieren

APA

Lyu, F., Gong, H., Wu, X., Liu, X., Lu, Y., Wei, X., Liu, C., Shen, Y., Wang, Y., Lei, L., Chen, J., Ma, S., Sun, H., Yu, D., Han, J., Xu, Y., & Wu, D. (2025). Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2. Leukemia. https://doi.org/10.1038/s41375-024-02475-5

Vancouver

Lyu F, Gong H, Wu X, Liu X, Lu Y, Wei X, et al. Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2. Leukemia. 2025. doi:10.1038/s41375-024-02475-5

BibTeX
@article{Lyu2025,
  author = {Lyu, Fulian and Gong, Huanle and Wu, Xiaojin and Liu, Xin and Lu, Yinghao and Wei, Xiya and Liu, Chenchen and Shen, Yaoyao and Wang, Yuhang and Lei, Lei and Chen, Jia and Ma, Shoubao and Sun, Hongjian and Yu, Di and Han, JingJing and Xu, Yang and Wu, Depei},
  title = {Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2},
  journal = {Leukemia},
  year = {2025},
  doi = {10.1038/s41375-024-02475-5}
}
Kostenlos starten →